Keyphrases
Kidney Transplant Recipients
100%
Mycophenolic Acid
100%
Patients with Diabetes Mellitus
100%
Enteric-coated Mycophenolate Sodium (EC-MPS)
71%
Mycophenolate Mofetil
57%
Gastrointestinal Diseases
42%
Type 1 Diabetes Mellitus (T1DM)
28%
Acid Exposure
28%
Symptom Burden
28%
Stomach
28%
Diabetic Kidney
28%
Type 2 Diabetes Mellitus (T2DM)
14%
Diabetic
14%
Gastrointestinal Tolerance
14%
Comparative Trial
14%
Patient-Reported Outcomes Measurement Information System (PROMIS)
14%
Patients with Diabetes
14%
Exposure Time
14%
Extended Duration
14%
Without Diabetes
14%
Non-diabetic Population
14%
Peak Concentration
14%
Gastrointestinal Complications
14%
Time to Peak
14%
Delayed Gastric Emptying
14%
Gut Contents
14%
Gastrointestinal Toxicity
14%
Oral Drug Absorption
14%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Mycophenolic Acid
100%
Mycophenolate Mofetil
33%
Gastrointestinal Symptom
25%
Drug Absorption
8%
Insulin Dependent Diabetes Mellitus
8%
Stomach Paresis
8%
Gastrointestinal Toxicity
8%
Non Insulin Dependent Diabetes Mellitus
8%